Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure
Nicolas Vodovar(Institut Pasteur), Alexandre Mebazaa(Délégation Paris 5), Riadh Boukef(Délégation Paris 7), Mark Richards(University of Otago), Marie‐France Seronde(Centre Hospitalier Universitaire de Besançon), James L. Januzzi(Massachusetts General Hospital), Jane‐Lise Samuel(Université Paris Cité), Johan Lassus(University of Helsinki), Étienne Gayat(Inserm), Sai͏̈d Laribi(Université de Tours), Damien Logeart(Inserm), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Philippe Manivet(Inserm), Semir Nouira(Hospital Fatuma Bourguiba Monastir), Alain Cohen Solal(Inserm), Shiro Ishihara(Nippon Steel Yawata Memorial Hospital)
Cited by 109
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k